Y Intercept Hong Kong Ltd Invests $868,000 in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Key Points

• Y Intercept Hong Kong Ltd has acquired 49,710 shares of Sabra Healthcare REIT, valued at approximately $868,000, during the first quarter of the year.
• Sabra Healthcare REIT's recent earnings report showed $0.37 EPS for the quarter, surpassing expectations and marking a 10.1% revenue increase compared to the previous year.
• The firm declared a quarterly dividend of $0.30 per share, yielding about 6.59%, while the dividend payout ratio stands at 203.39%.

Y Intercept Hong Kong Ltd acquired a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 49,710 shares of the real estate investment trust's stock, valued at approximately $868,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. UMB Bank n.a. raised its holdings in shares of Sabra Healthcare REIT by 379.6% in the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after acquiring an additional 1,621 shares during the last quarter. Fifth Third Bancorp raised its holdings in shares of Sabra Healthcare REIT by 110.3% in the 1st quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock worth $67,000 after acquiring an additional 2,011 shares during the last quarter. GF Fund Management CO. LTD. acquired a new stake in shares of Sabra Healthcare REIT in the 4th quarter worth about $74,000. Harbor Capital Advisors Inc. raised its holdings in shares of Sabra Healthcare REIT by 17.2% in the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock worth $76,000 after acquiring an additional 642 shares during the last quarter. Finally, IFP Advisors Inc raised its holdings in shares of Sabra Healthcare REIT by 16.2% in the 1st quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust's stock worth $88,000 after acquiring an additional 706 shares during the last quarter. Institutional investors own 99.40% of the company's stock.

Sabra Healthcare REIT Stock Up 1.0%

NASDAQ:SBRA traded up $0.19 on Tuesday, hitting $18.17. The stock had a trading volume of 421,596 shares, compared to its average volume of 2,401,573. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.22 and a current ratio of 4.22. The stock has a market cap of $4.32 billion, a P/E ratio of 30.80, a price-to-earnings-growth ratio of 1.51 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03. The firm's fifty day simple moving average is $18.09 and its two-hundred day simple moving average is $17.47.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, beating the consensus estimate of $0.36 by $0.01. The firm had revenue of $183.54 million during the quarter, compared to analyst estimates of $180.23 million. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The company's revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter last year, the business posted $0.35 EPS. Analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 16th. This represents a $1.20 annualized dividend and a yield of 6.61%. Sabra Healthcare REIT's dividend payout ratio (DPR) is 203.39%.

Wall Street Analysts Forecast Growth

Separately, Scotiabank upped their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $19.67.

Insider Buying and Selling

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the completion of the sale, the director owned 64,725 shares in the company, valued at approximately $1,179,289.50. This trade represents a 14.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.10% of the company's stock.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.